Legal & General Group
SMMT icon

Legal & General Group’s Summit Therapeutics SMMT Stock Holding History

Legal & General Group’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$266K Sell
18,247
-13,645
-43% -$242K ﹤0.01% 2520
2026
Q1 		$605K Buy
31,892
+4,533
+17% +$73.3K ﹤0.01% 2302
2025
Q4 		$479K Buy
27,359
+823
+3% +$15.5K ﹤0.01% 2445
2025
Q3 		$548K Buy
26,536
+169
+0.6% +$4.1K ﹤0.01% 2429
2025
Q2 		$561K Buy
26,367
+6,662
+34% +$152K ﹤0.01% 2412
2025
Q1 		$380K Buy
19,705
+9,644
+96% +$193K ﹤0.01% 2486
2024
Q4 		$180K Buy
10,061
+342
+4% +$6.63K ﹤0.01% 2673
2024
Q3 		$213K Sell
9,719
-9,212
-49% -$129K ﹤0.01% 2673
2024
Q2 		$148K Sell
18,931
-98,687
-84% -$533K ﹤0.01% 2702
2024
Q1 		$487K Sell
117,618
-1,386
-1% -$5.51K ﹤0.01% 2438
2023
Q4 		$311K Buy
119,004
+909
+0.8% +$1.87K ﹤0.01% 2615
2023
Q3 		$221K Buy
118,095
+7,480
+7% +$14.3K ﹤0.01% 2704
2023
Q2 		$278K Buy
+110,615
New +$202K ﹤0.01% 2658
2022
Q2 		– Sell
-2,770
Closed -$7K – 3643
2022
Q1 		$7K Hold
2,770
– – ﹤0.01% 3471
2021
Q4 		$7K Hold
2,770
– – ﹤0.01% 3521
2021
Q3 		$14K Buy
2,770
+391
+16% +$2.81K ﹤0.01% 3381
2021
Q2 		$18K Buy
+2,379
New +$15.6K ﹤0.01% 3334

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Legal & General Group's SMMT Position: Q2 2026 in Review

Legal & General Group reduced its Summit Therapeutics (SMMT) stake by 43% in Q2 2026, selling an estimated $242K and leaving 18,247 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #2520.

Legal & General Group first reported a position in SMMT in Q2 2021 and has held it in 17 quarters since. The position peaked at $605K in Q1 2026. 242 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • Legal & General Group held 18,247 shares of Summit Therapeutics worth $266K as of Q2 2026.
  • Legal & General Group sold 13,645 Summit Therapeutics shares in Q2 2026, an estimated $242K.
  • Summit Therapeutics made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2520 holding.
  • Legal & General Group first reported a position in Summit Therapeutics in Q2 2021 and has held it in 17 quarters since.
  • Legal & General Group's Summit Therapeutics position peaked at $605K in Q1 2026.
  • 242 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.